Planview Blog

Your path to business agility

Product Portfolio Management, Project Portfolio Management, Strategic Planning

Upcoming Portfolio Management Conferences in 2019 – Enrich Consulting

Published By Dr. Richard Sonnenblick

Are you interested in networking with other innovation professionals and learning about best practices in R&D allocation? Here are three conferences we’ll be sponsoring in the coming months:

Unleashing Innovation, June 13 and 14, Amsterdam

This conference is cross industry, with R&D firms from all over Europe in attendance. We’ve been away for two years and are looking forward to returning to this annual event.

Project & Portfolio Management for Pharma, July 24 and 25, San Francisco

Fleming usually holds this conference on the East Coast, but this year it’ll be in our backyard here in California. We’re looking forward to networking with some of the many start-ups and biotech companies that make their home on the West Coast and may not venture to events in Boston, NYC, or Philadelphia.

Portfolio Management and Strategic Resource Management, October 16-18, Philadelphia

This three-day conference devotes the first day-and-a-half to resource planning challenges before diving into more strategic aspects of portfolio management. While it is focused on drug development and medical devices, there are always a few people from other industries interested in hearing about best-practices from the life sciences.

Finally, CEO Richard Sonnenblick is running a workshop on innovation prioritization for the Innovation Research Interchange in Fort Worth during their Fall Networks Conference in late September. These IRI events are smaller than their semi-annual meetings and are a great place to network with other innovators in medium to large companies around the US.

We hope to see you at one or more of these conferences. If you’d like to arrange a chat while we’re on-site, let us know!

Related Posts

Written by Dr. Richard Sonnenblick Chief Data Scientist

Dr. Sonnenblick, Planview’s Chief Data Scientist, holds years of experience working with some of the largest pharmaceutical and life sciences companies in the world. Through this in-depth study and application, he has successfully formulated insightful prioritization and portfolio review processes, scoring systems, and financial valuation and forecasting methods for enhancing both product forecasting and portfolio analysis. Dr. Sonnenblick holds a Ph.D. and MS from Carnegie Mellon University in Engineering and Public Policy and a BA in Physics from the University of California, Santa Cruz.